EN
DE
Home
About us
Biofronteras Expertise
Management and supervisory board
Product Pipeline
Clinical trials
Products
Product Portfolio
Investors & Media
Current capital measure
Key stock information
Financial reports
Financial announcements
Shareholder structure
Corporate calendar
Corporate governance
Annual general meeting
Presentations & contact
Career
Careers
Contact
Biofrontera
Investors & Media
Financial announcements
Latest News Releases
06/13/2024 16:30
PTA-News: Biofrontera AG: Biofrontera AG announces the registration of the capital increase
06/03/2024 19:55
PTA-Adhoc: Biofrontera AG: Biofrontera AG reports result of the capital increase resolved on April 04, 2024
05/31/2024 09:05
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST QUARTER OF 2024
05/14/2024 10:30
PTA-News: Biofrontera AG: Biofrontera strategically on course for growth; Realignment of the Supervisory Board
05/08/2024 17:00
PTA-News: Biofrontera AG: Biofrontera executes capital reduction and capital increase
05/06/2024 16:50
PTA-Adhoc: Biofrontera AG: CHANGES IN THE SUPERVISORY BOARD
04/30/2024 10:15
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FINANCIAL YEAR 2023
04/04/2024 19:45
PTA-Adhoc: Biofrontera AG: Biofrontera AG resolves capital increase from authorized capital
02/20/2024 14:15
PTA-News: Biofrontera AG: Biofrontera transfers clinical research to the U.S.
02/20/2024 13:45
PTA-Adhoc: Biofrontera AG: Biofrontera AG announces revised strategy
Financial announcements
Material News
Current & Archive (Related Party Transactions incl.)
Corporate News
Current & Archive
Voting Rights
Notifications
Current & Archive
Directors' Dealings
Current & Archive